Last10K.com

Abbott Laboratories (ABT) SEC Filing 8-K Material Event for the period ending Friday, February 18, 2022

Abbott Laboratories

HISTORY TOOLS
CIK: 1800 Ticker: ABT

View differences made from one to another to evaluate Abbott Laboratories's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Abbott Laboratories.

Continue

Assess how Abbott Laboratories's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Abbott Laboratories's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover

Material Contracts, Statements, Certifications & more

Abbott Laboratories provided additional information to their SEC Filing as exhibits

Exhibit 3.1: Articles Of Incorporation
Ticker: ABT
CIK: 1800
Form Type: 8-K Corporate News
Accession Number: 0001104659-22-025612
Submitted to the SEC: Tue Feb 22 2022 4:04:48 PM EST
Accepted by the SEC: Tue Feb 22 2022
Period: Friday, February 18, 2022
Industry: Pharmaceutical Preparations
Events:
  1. Bylaw Change
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/abt/0001104659-22-025612.htm